• Fatigue after initiating rivaroxaban for venous thromboembolism 

      Karlsvik, Tina Margrethe; Borgenvik, Thore Langfeldt; Aadalen, Mirjam; Utne, Kristin Kornelia; Førsund, Eli; Jørgensen, Camilla Tøvik; Holst, René; Jelsness-Jørgensen, Lars-Petter; Ghanima, Waleed Khalid (Peer reviewed; Journal article, 2020-03-09)
      Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...
    • Fatigue after initiating rivaroxaban for venous thromboembolism 

      Karlsvik, Tina Margrethe; Borgenvik, Thore Langfeldt; Aadalen, Mirjam; Utne, Kristin Kornelia; Førsund, Eli; Jørgensen, Camilla Tøvik; Holst, René; Jelsness-Jørgensen, Lars-Petter; Ghanima, Waleed Khalid (Peer reviewed; Journal article, 2020-03-09)
      Background. Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...
    • Health‑related quality of life after deep vein thrombosis 

      Utne, Kristin Kornelia; Tavoly, Mazdak; Wik, Hilde Skuterud; Jelsness‑Jørgensen, Lars Petter; Holst, René; Sandset, Per Morten; Ghanima, Waleed (Journal article; Peer reviewed, 2016)
      Background: Health-related quality of life (HRQoL) is known to be impaired in patients who develop post-thrombotic syndrome (PTS) following deep vein thrombosis (DVT). However, there is limited knowledge of the long-term HRQoL ...
    • Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial 

      Haukeland-Parker, Stacey Marie; Jervan, Øyvind; Johannessen, Hege Hølmo; Gleditsch, Jostein; Stavem, Knut; Steine, Kjetil; Spruit, Martijn A.; Holst, René; Tavoly, Mazdak; Ghanima, Waleed Khalid (Peer reviewed; Journal article, 2021)